Related Experiment Video
Updated: May 6, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Current readings: Surgical management of heart failure
Kevin W Southerland1, Carmelo A Milano
1Department of Surgery. Duke University Medical Center, Durham, North Carolina..
Insights
Surgical options for end-stage congestive heart failure include coronary revascularization and mitral valve repair, offering clear benefits. Cardiac stem cell therapies show promise, but volume-reduction strategies need more research.
Area of Science:
- Cardiovascular Surgery
- Regenerative Medicine
Background:
- End-stage congestive heart failure presents complex therapeutic challenges.
- Numerous surgical interventions are available for managing advanced heart failure.
Purpose of the Study:
- To review current surgical therapies for end-stage congestive heart failure.
- To evaluate the clinical utility and future potential of various surgical approaches.
Main Methods:
- Literature review of established and emerging surgical treatments.
- Analysis of clinical benefits and evidence for different strategies.
Main Results:
- Coronary revascularization and mitral valve repair demonstrate established clinical benefits in selected patients.
- Volume-reduction strategies require further investigation prior to widespread adoption.
- Cardiac stem cell therapies have shown encouraging outcomes in early-stage research.
Conclusions:
- Established surgical procedures remain crucial for selected heart failure patients.
- Emerging therapies like stem cell treatments warrant continued development.
- Further research is essential to optimize treatment algorithms for advanced heart failure.
Abstract:
There are a myriad of surgical therapies for patients with end-stage congestive heart failure. Coronary revascularization and mitral valve repair have clear clinical benefits in appropriately selected patients. Further investigation is required before the widespread adoption of volume-reduction strategies. Cardiac stem cell therapies have yielded promising results in preclinical and phase I studies.
More Related Videos
Related Concept Videos
Heart Failure V: Medical Management
Mitral Regurgitation IV: Nursing Management
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Rheumatic Heart Disease III: Medical Management

